ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AIM AIM ImmunoTech Inc

0.3969
0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
AIM ImmunoTech Inc AIM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.3969 04:00:00
Open Price Low Price High Price Close Price Prev Close
0.3969
more quote information »

Recent News

Date Time Source Heading
5/20/202409:15GLOBEAIM ImmunoTech to Participate in Two Upcoming Investor..
5/16/202407:30GLOBEAIM ImmunoTech Reports First Quarter 2024 Financial Results..
5/15/202416:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202408:50GLOBEAIM ImmunoTech to Discuss First Quarter 2024 Financial..
5/07/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202408:30GLOBEAIM ImmunoTech Completes cGMP Manufacturing of Clinical..
4/29/202408:55GLOBEAIM ImmunoTech Announces First Dose Level is Generally..
4/25/202408:45GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
4/18/202408:45GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
4/15/202408:55GLOBEAIM ImmunoTech Announces Charles Lapp, MD, as a Consulting..
4/11/202411:00GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
4/10/202408:21GLOBEAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
4/02/202407:30GLOBEAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
3/28/202408:05GLOBEAIM ImmunoTech to Present at the MedInvest Biotech & Pharma..
3/26/202409:05GLOBEAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
3/25/202409:05GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
3/22/202408:55GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
3/20/202409:25GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
3/15/202408:45GLOBEAIM ImmunoTech to Participate in the Virtual Investor Lunch..
3/07/202408:45GLOBEAIM ImmunoTech Announces Launch of CEO Corner Platform
2/29/202408:45GLOBEAIM ImmunoTech Outlines Recent Progress Across Clinical..
2/21/202410:37EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
2/20/202416:31EDGAR2Form 8-K - Current report
2/14/202408:55GLOBEAIM ImmunoTech Announces First Subject Dosed in the..
2/09/202415:47EDGAR2Form 8-K - Current report
2/08/202408:50GLOBEAIM ImmunoTech Reports Positive Topline Results from Phase 2..
1/25/202417:00EDGAR2Form 8-K - Current report
1/24/202409:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
1/22/202408:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
1/10/202413:42EDGAR2Form 8-K - Current report
1/10/202408:45EDGAR2Form 8-K - Current report
1/10/202408:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
1/05/202413:32BWAIM Shareholders Elect All Four Company Director Nominees at..
1/03/202416:24EDGAR2Form SC 13D/A - General statement of acquisition of..
1/03/202416:24EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
1/03/202416:05PRNUSKellner Seeking Expedited Appeal of Delaware Court Finding..
12/29/202308:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/29/202308:00BWDelaware Court Rules in Favor of AIM ImmunoTech and Upholds..
11/28/202316:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/28/202316:30BWAIM ImmunoTech Provides Update Regarding Annual Meeting
11/27/202312:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/27/202309:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
11/21/202312:00GLOBEAIM ImmunoTech Completes Treatment of Last Subject in Phase..
11/20/202317:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/20/202309:05EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
11/20/202307:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/16/202309:21EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
11/15/202307:30EDGAR2Form 8-K - Current report
11/15/202307:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..

Your Recent History

Delayed Upgrade Clock